Singapore, June 19 -- Japan-based NEC Corporation, in collaboration withChugaiPharmaceutical Co., has conducted an experiment using artificial intelligence (AI) to predict drug combinations that can possibly enhance the effectiveness of certain cancer treatments.

As a result, the time required to produce predictions may potentially be reduced by approximately 50% when compared toChugai's conventional methods.

Drug combination therapy, in which two or more drugs are used in combination, is a promising option in the treatment of cancer. This therapy is expected to have a higher therapeutic effect than when single agents are administered. However, the prediction of drug combinations has conventionally required time-consuming manual researc...